Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in IndiaPRNewsWire • 09/19/24
Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer TrialPRNewsWire • 09/16/24
Aethlon Medical to Present at the Life Sciences Investor Forum September 19thGlobeNewsWire • 09/13/24
Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor KidneysPRNewsWire • 08/27/24
Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate UpdatePRNewsWire • 08/14/24
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid TumorsNewsfile Corp • 08/12/24
Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer TrialPRNewsWire • 08/12/24
Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024PRNewsWire • 08/06/24
Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate UpdatePRNewsWire • 06/27/24
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024PRNewsWire • 06/21/24
Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer TrialPRNewsWire • 06/18/24
Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVIDNewsfile Corp • 06/03/24
Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment StudiesPRNewsWire • 06/03/24
Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient PlasmaPRNewsWire • 05/10/24
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture DevicesPRNewsWire • 02/21/24